# GoodRx (NASDAQ:GDRX) & COMPASS Pathways (NASDAQ:CMPS) Financial Review

- URL: https://theranews.net/blog/2025-12-26-goodrx-nasdaqgdrx-compass-pathways-nasdaqcmps-financial-review-77d642/
- Published: 2025-12-26
- Type: Archive summary (AI-assisted summary of third-party reporting)
- Original outlet: thelincolnianonline
- Original report: https://www.thelincolnianonline.com/2025/12/25/goodrx-nasdaqgdrx-compass-pathways-nasdaqcmps-financial-review.html
- Topics: mental-health
- Publisher: TheraNews, operated by AdvancedCare USA Inc.
- Notice: Educational content, not medical, legal, billing or financial advice. Cite the original outlet, not this summary.

> COMPASS Pathways (NASDAQ:CMPS – Get Free Report) and GoodRx (NASDAQ:GDRX – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their profitability, valuation, risk, analyst recommendations, institutional ow

---
![GoodRx (NASDAQ:GDRX) & COMPASS Pathways (NASDAQ:CMPS) Financial Review](/uploads/news-images/goodrx-nasdaq-gdrx-compass-pathways-nasdaq-cm-20251226230118.jpeg) ---
*Originally reported by thelincolnianonline. [Read more](https://www.thelincolnianonline.com/2025/12/25/goodrx-nasdaqgdrx-compass-pathways-nasdaqcmps-financial-review.html)*

---

*Source: [https://www.thelincolnianonline.com/2025/12/25/goodrx-nasdaqgdrx-compass-pathways-nasdaqcmps-financial-review.html](https://www.thelincolnianonline.com/2025/12/25/goodrx-nasdaqgdrx-compass-pathways-nasdaqcmps-financial-review.html)*